Oklo stock jumps as Meta backs 1.2-GW Ohio nuclear power campus for AI data centers

Oklo stock jumps as Meta backs 1.2-GW Ohio nuclear power campus for AI data centers

New York, January 9, 2026, 12:06 PM EST — Regular session

  • Oklo shares rise about 11% after Meta agreement tied to a 1.2-gigawatt Ohio project
  • Meta also struck nuclear power deals with Vistra and TerraPower as AI power demand climbs
  • Investors focus on permits, funding details and Oklo’s next quarterly update

Oklo Inc (OKLO) shares rose sharply on Friday after the company said it reached an agreement with Meta Platforms to support development of a 1.2-gigawatt nuclear energy campus in southern Ohio. Oklo was up $11.22, or about 11.5%, at $108.82, after trading as high as $120.87 on volume of about 22.1 million shares. 1

The deal lands as big tech firms hunt for long-term power as artificial intelligence and data centers push U.S. electricity demand higher. Meta said it has also struck 20-year power purchase agreements with Vistra and will help develop planned small modular reactors with Oklo and TerraPower, with the package aimed at providing up to 6.6 gigawatts of nuclear power by 2035. 2

The move also lifted other names tied to nuclear and power generation. Vistra was up about 12%, NuScale Power added about 6%, and Constellation Energy gained about 5%, while Meta shares were up about 1%.

Oklo said Meta’s agreement sets up a way for Meta to prepay for power and fund early procurement, including nuclear fuel, for the first phase of what Oklo calls its Aurora powerhouse project in Pike County. “Today, that vision is becoming a reality,” Oklo co-founder and CEO Jacob DeWitte said, while Meta energy chief Urvi Parekh called it a project that “will create jobs.” 3

The Meta news follows another Oklo update earlier this week. Oklo said it signed a U.S. Department of Energy Other Transaction Agreement to support the design, construction and operation of a radioisotope pilot plant under the DOE Reactor Pilot Program, and said its Atomic Alchemy subsidiary pulled a previously submitted NRC construction permit application tied to a separate radioisotope project. 4

But the trade is still built on long timelines. Small modular reactors — smaller nuclear units pitched as easier to build and deploy than traditional plants — are not yet running commercially in the United States, and analysts and industry critics have warned that costs and permitting could still bite as projects move from pitch decks to concrete. 5

Investors have also been watching supply in the stock. A Form 144 filing dated Jan. 7 disclosed a proposed sale of 655,000 Oklo shares, with an aggregate market value listed at about $62.6 million. 6

What comes next is less about today’s headline and more about paperwork and cash. Oklo has not announced a date for its next earnings release, but Zacks expects the next report around March 23, when investors will be listening for updates on funding, fuel procurement and the permitting path tied to the Ohio buildout. 7

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Why Mirion Technologies stock is jumping today as Meta’s nuclear deals jolt the sector
Previous Story

Why Mirion Technologies stock is jumping today as Meta’s nuclear deals jolt the sector

Ford stock slips today after Piper upgrade pop as investors weigh Ford’s “eyes-off” driving push
Next Story

Ford stock slips today after Piper upgrade pop as investors weigh Ford’s “eyes-off” driving push

Go toTop